Accessibility Menu
 

OS Therapies

(NYSEMKT) OSTX

Current Price$1.77
Market Cap$74.41M
Since IPO (2024)-29%
5 YearN/A
1 Year+10%
1 Month+23%

OS Therapies Financials at a Glance

Market Cap

$74.41M

Revenue (TTM)

$0.00

Net Income (TTM)

$28.75M

EPS (TTM)

$-0.94

P/E Ratio

-1.88

Dividend

$0.00

Beta (Volatility)

1.56 (High)

Price

$1.77

Volume

26,989

Open

$1.80

Previous Close

$1.77

Daily Range

$1.70 - $1.82

52-Week Range

$1.15 - $2.57

OSTX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About OS Therapies

Industry

Biotechnology

Employees

5

CEO

Paul A. Romness

Headquarters

Rockville, MD 21638, US

OSTX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-914%

Return on Capital

6%

Return on Assets

-4%

Earnings Yield

-53.19%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$74.41M

Shares Outstanding

42.04M

Volume

26.99K

Short Interest

0.00%

Avg. Volume

582.99K

Financials (TTM)

Gross Profit

$363.08K

Operating Income

$28.71M

EBITDA

$28.39M

Operating Cash Flow

$14.24B

Capital Expenditure

$466.42K

Free Cash Flow

$14.24B

Cash & ST Invst.

$269.83M

Total Debt

$0.00

OS Therapies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$124.94K

-8888.3%

Gross Margin

0.00%

N/A

Market Cap

$74.41M

N/A

Market Cap/Employee

$18.60M

N/A

Employees

4

N/A

Net Income

$13.46M

-350.0%

EBITDA

$13.34M

-347.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$269.83M

+4776.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-4.20%

N/A

Return on Invested Capital

5.83%

N/A

Free Cash Flow

$3.73M

-57.1%

Operating Cash Flow

$3.73M

-57.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EQEquillium, Inc.
$2.04-5.56%
SPRBSpruce Biosciences, Inc.
$57.18+5.17%
COEPCoeptis Therapeutics, Inc.
$16.40+0.00%
INKTMiNK Therapeutics, Inc.
$11.14+1.74%

Trending Stocks

Symbol / CompanyPricePrice Chg
POETPoet Technologies
$7.95-0.47%
NOKNokia
$10.76+0.03%
OGNOrganon & Co.
$13.16+0.17%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.32+0.01%

Questions About OSTX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.